Navigation Links
Novocure Presents Preclinical Data at the American Association for Cancer Research (AACR)
Date:4/10/2013

WASHINGTON, April 10, 2013 /PRNewswire/ -- Novocure announced today that new data from preclinical testing of NovoTTF Therapy in non-small cell lung carcinoma (NSCLC), ovarian and pancreatic cancer has been presented at the 2013 AACR Annual Meeting.  The new data builds on existing published research describing the potential efficacy of NovoTTF Therapy in a wide range of solid tumors.

"The results presented at the AACR Annual Meeting demonstrate that NovoTTF Therapy inhibits the growth of squamous histology non-small cell lung cancer as well as pancreatic and ovarian cancers in preclinical models," said Eilon Kirson , M.D., Ph.D., Novocure's Chief Science Officer and Head of Research and Development.  "We intend to build on this research through clinical trials evaluating the efficacy of NovoTTF Therapy in these indications when delivered in combination with chemotherapy."

AACR Annual Meeting 2013 Abstracts

  • Giladi et al, Development of an orthotopic squamous cell carcinoma (SCC) lung cancer model.  Data were presented describing a new in vivo model to test the efficacy of anti-neoplastic treatments in SCC lung cancer.  Abstract #340.
  • Giladi et al, NovoTTF Therapy inhibited the growth of pancreatic and ovarian cancer in vitro. Additionally, the data supports a conclusion that modulation of NovoTTF Therapy frequency may overcome treatment resistance. Abstract #5569.

About NovoTTF Therapy
NovoTTF Therapy is delivered by portable, non-invasive medical devices designed for continuous use throughout the day by the patient. NovoTTF Therapy has been shown in in vitro and in vivo studies to slow and reverse tumor growth by inhibiting mitosis, the process by which cells divide and replicate. The delivery systems weigh about six pounds and create a low intensity, alternati
'/>"/>

SOURCE Novocure
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Novocure™ to Present NovoTTF™ Therapy Data at the 2012 Annual Scientific Meeting of the American Society of Clinical Oncology
2. Study Results of Novocures NovoTTF™ Pivotal Phase 3 Trial Published in European Journal of Cancer
3. DelMar Pharma Presents Encouraging Data From Ongoing Phase I/II GBM Clinical Trial With VAL-083
4. NewGen Therapeutics Presents Data on NT-113, A Novel Pan-ErbB Inhibitor, at American Association of Cancer Research
5. Exosome Presents Late-Breaking Study Demonstrating Ability to Profile RNA from Archived Clinical Trial Blood Samples at 2013 American Association of Cancer Research Annual Meeting
6. Cardium Presents Year-End 2012 Financial Results And Recent Developments
7. Pharmagen Presents to North Carolina General Assembly at N.C. Bios Legislative Breakfast
8. NewLink Genetics Presents Preclinical Data on NLG919, a New Drug Candidate from a Novel Class of IDO Pathway Inhibitors for the Treatment of Cancer
9. Upsher-Smith Presents Data Supporting Favorable Tolerability And Consistent Pharmacokinetic Profile Of Once-Daily USL255 (Extended-Release Topiramate)
10. Versus Presents New Hand-Hygiene Alliance, Wireless Sensors and RTLS Education at HIMSS13
11. University Hospitals Case Medical Center Presents Study On The Elimination Of Retained Surgical Sponges
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... 2014  Zimmer Holdings, Inc. (NYSE and SIX: ZMH) ... European Commission (the "EC") to extend the deadline for ... by a limited number of days in order to ... Deadline extensions are not uncommon in such in-depth ... authorities to facilitate their review of the pending transaction ...
(Date:11/18/2014)... Pharmaceuticals, Inc. (NASDAQ: ISIS ) announced today that ... 2014 at 9:00 a.m. Eastern Time to discuss the ISIS-FXI ... Society of Hematology Annual Meeting and Exposition.  ... or access the webcast at www.isispharm.com .  A webcast ... same address. ABOUT ISIS PHARMACEUTICALS, INC. ...
(Date:11/18/2014)... 18, 2014  AgeneBio, a pharmaceutical company developing ... restore brain function, today announced that the Company,s ... , PhD, has received the Society for Neuroscience,s ... 35 years, Dr. Gallagher,s research at Johns Hopkins ... Hill has led to advancements in the field ...
Breaking Medicine Technology:Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 2Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 3Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 4Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 5Isis Pharmaceuticals to Host Webcast to Discuss ISIS-FXI Rx Data Presented at the ASH Annual Meeting 2Isis Pharmaceuticals to Host Webcast to Discuss ISIS-FXI Rx Data Presented at the ASH Annual Meeting 3AgeneBio Founder and Chief Scientific Officer Receives Society for Neuroscience's Mika Salpeter Lifetime Achievement Award 2AgeneBio Founder and Chief Scientific Officer Receives Society for Neuroscience's Mika Salpeter Lifetime Achievement Award 3
(Date:11/18/2014)... 18, 2014 A+ Secure Packaging, ... nutraceutical, dietary supplements and more, announced today that ... Good Manufacturing Practices (GMP) Registration for dietary supplements ... from NSF International verifies the A+ Secure Packaging ... compliance requirements of its clients by demonstrating the ...
(Date:11/18/2014)... Newport Beach, CA (PRWEB) November 18, 2014 ... settle into new routines, many people look at fall ... the holidays. Dr. Kevin Sadati , Orange County ... at this Newport Beach practice. At the Gallery ... his patients taking advantage of his non-invasive cosmetic surgery ...
(Date:11/18/2014)... Haelle HealthDay Reporter MONDAY, ... experience a severe abusive head trauma before the age of ... new study. In addition, among those who survive ... the study found. Abusive head trauma includes shaken baby ... suffers head injuries, according to background information in the study. ...
(Date:11/18/2014)... HealthDay Reporter , MONDAY, Nov. 17, ... not have significant heart-health benefits for older people, new ... than 14,000 Japanese people aged 60 to 85, found ... attacks and strokes between people who took aspirin and ... prevention with daily low-dose aspirin does not reduce the ...
(Date:11/18/2014)... Dennis Thompson HealthDay ... Heart attack and stroke patients can safely take aspirin combined ... blood-thinning combination won,t increase a patient,s risk of early death, ... meeting of the American Heart Association in Chicago. The report ... . Analysis of data from more than a dozen ...
Breaking Medicine News(10 mins):Health News:A+ Secure Packaging, LLC Earns NSF International Good Manufacturing Practices (GMP) Registration for Dietary Supplements and Certification for Sport 2Health News:Orange County Facial Plastic Surgeon, Dr. Kevin Sadati Observes a New Trend of Non-invasive Cosmetic Surgery Procedures Becoming Increasingly Popular This Fall 2Health News:Orange County Facial Plastic Surgeon, Dr. Kevin Sadati Observes a New Trend of Non-invasive Cosmetic Surgery Procedures Becoming Increasingly Popular This Fall 3Health News:Head Trauma in Abused Babies, Toddlers Can Have Lifelong Impact 2Health News:Head Trauma in Abused Babies, Toddlers Can Have Lifelong Impact 3Health News:Head Trauma in Abused Babies, Toddlers Can Have Lifelong Impact 4Health News:Daily Aspirin Fails to Help Older Hearts in Japanese Study 2Health News:Daily Aspirin Fails to Help Older Hearts in Japanese Study 3Health News:Long-Term Use of Aspirin Plus Blood Thinner Is Safe: Study 2Health News:Long-Term Use of Aspirin Plus Blood Thinner Is Safe: Study 3
... News) -- Many children who,ve lost a sister or brother ... as a result of the experience, new research finds. ... Nursing , researchers from Nationwide Children,s Hospital in Columbus, Ohio, ... a sibling impacted them one year later. Siblings were ...
... New breast cancer screening guidelines for women at ... (Canadian Medical Association Journal) (pre-embargo link only) ... women aged 40-49 and extend the screening interval ... practice, to every 2 to 3 years for ...
... 2011) -- Older adults receiving home health care may be ... their age. In fact, nearly 40 percent of seniors receiving ... least one prescription medication that is considered potentially inappropriate to ... Internal Medicine has revealed. The study,s researchers, led ...
... find the main culprit behind the dry, irritated eyes, ... of the population., It,s called Sjgren,s syndrome, a painful ... 6.5 years to diagnose and is difficult to treat. ... how it develops should improve diagnosis and treatment. , ...
... of Michigan Medical School and MedImmune, the global biologics ... work together on a broad range of projects. ... of the nation,s top medical research institutions together with ... biologic therapies. UMMS and MedImmune scientists will ...
... Institutet have developed a new method for counting molecules. ... DNA molecules is a fundamental task in molecular biology ... in cells. Thus, improved measurement techniques are crucial for ... very difficult to detect small individual molecules in a ...
Cached Medicine News:Health News:Siblings Deeply Affected By Child's Cancer Death 2Health News:New breast cancer screening guidelines released 2Health News:New breast cancer screening guidelines released 3Health News:Older adults in home health care at elevated risk for unsafe meds 2Health News:Researchers search for culprit behind dry eyes, mouths and more 2Health News:Researchers search for culprit behind dry eyes, mouths and more 3Health News:U-M Medical School and MedImmune join forces to accelerate search for new therapies 2Health News:A better way to count molecules discovered 2
The PillCam™ ESO video capsule is specifically designed to view the inner lining of the Esophagus. The capsule is equipped with miniature cameras on both ends and is about the size of a multi-v...
... Radi invented the guidewire-mounted pressure ... way. PressureWire5 Sensor is the only ... pressure, temperature and flow. With significantly ... serves as your primary guidewire, as ...
... ultrasound and MRI-guided vacuum assisted breast biopsies ... the patented, FDA-cleared ATEC system for a ... method of breast biopsy. Its compassionate care ... trust YOU.,9 Gauge Handpieces: Useful for biopsy ...
Three-spring evacuator kits with silicone drains, 10 in. hole pattern, trocar and Y-connector tubing...
Medicine Products: